SELLAS Life Sciences Group, Inc. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9765afb8-7d03-4788-ae6b-234d302406fb/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001390478-24-000004 |
| FY 2022 | $1.0M | 2022-01-01 – 2022-12-31 | evidence 0001390478-23-000005 |
| FY 2021 | $7.6M | 2021-01-01 – 2021-12-31 | evidence 0001390478-22-000006 |
| FY 2020 | $1.9M | 2020-01-01 – 2020-12-31 | evidence 0001390478-21-000007 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001390478-21-000007 |
| FY 2014 | $9.3M | 2014-01-01 – 2014-12-31 | evidence 0001390478-15-000012 |
| FY 2013 | $2.5M | 2013-01-01 – 2013-12-31 | evidence 0001390478-14-000016 |
| FY 2012 | $0 | 2012-01-01 – 2012-12-31 | evidence 0001390478-14-000016 |
| FY 2011 | $0 | 2011-01-01 – 2011-12-31 | evidence 0001390478-14-000016 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SELLAS Life Sciences Group, Inc. — all facts · Net Income · Operating Income